Intra-Cellular Therapies Inc (NASDAQ:ITCI)

Delayed Data
As of Jan 27
 -2.35 / -4.92%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Intra-Cellular Therapies Inc have a median target of 59.00, with a high estimate of 88.00 and a low estimate of 40.00. The median estimate represents a +30.01% increase from the last price of 45.38.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Intra-Cellular Therapies Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.26%
Growthannually -7.04%


Growthquarterly 14.17%
Growthannually 265.00%
Key to the earnings and sales forecast charts.